Advertisement

 

 

Integrating linear optimization with structural modeling to increase HIV neutralization breadth.

Integrating linear optimization with structural modeling to increase HIV neutralization breadth.
Author Information (click to view)

Sevy AM, Panda S, Crowe JE, Meiler J, Vorobeychik Y,


Sevy AM, Panda S, Crowe JE, Meiler J, Vorobeychik Y, (click to view)

Sevy AM, Panda S, Crowe JE, Meiler J, Vorobeychik Y,

Advertisement

PLoS computational biology 2018 02 1614(2) e1005999 doi 10.1371/journal.pcbi.1005999

Abstract

Computational protein design has been successful in modeling fixed backbone proteins in a single conformation. However, when modeling large ensembles of flexible proteins, current methods in protein design have been insufficient. Large barriers in the energy landscape are difficult to traverse while redesigning a protein sequence, and as a result current design methods only sample a fraction of available sequence space. We propose a new computational approach that combines traditional structure-based modeling using the Rosetta software suite with machine learning and integer linear programming to overcome limitations in the Rosetta sampling methods. We demonstrate the effectiveness of this method, which we call BROAD, by benchmarking the performance on increasing predicted breadth of anti-HIV antibodies. We use this novel method to increase predicted breadth of naturally-occurring antibody VRC23 against a panel of 180 divergent HIV viral strains and achieve 100% predicted binding against the panel. In addition, we compare the performance of this method to state-of-the-art multistate design in Rosetta and show that we can outperform the existing method significantly. We further demonstrate that sequences recovered by this method recover known binding motifs of broadly neutralizing anti-HIV antibodies. Finally, our approach is general and can be extended easily to other protein systems. Although our modeled antibodies were not tested in vitro, we predict that these variants would have greatly increased breadth compared to the wild-type antibody.

Submit a Comment

Your email address will not be published. Required fields are marked *

3 + 20 =

[ HIDE/SHOW ]